World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
116
Citations
43657
World Ranking
4398
National Ranking
2402

Overview

Colin P. Dinney is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on medicine, with significant work in surgery, molecular biology, oncology, urology, and pulmonary and respiratory medicine.

The scientist's research concentrates on several key areas, including bladder and urothelial cancer treatments, urinary and genital oncology studies, epigenetics and DNA methylation, urological disorders and treatments, cancer immunotherapy and biomarkers, cancer research and treatments, and esophageal cancer research and treatment.

Colin P. Dinney has contributed numerous papers across leading scientific venues. These include:

  • Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial (2020) in The Lancet Oncology
  • Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma (2020) in Nature Medicine
  • Assessment of Luminal and Basal Phenotypes in Bladder Cancer (2020) in Scientific Reports
  • Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with bacillus Calmette-Guérin: Implications for Clinical Trial Design (2021) in The Journal of Urology
  • Updated European Association of Urology (EAU) Prognostic Factor Risk Groups Overestimate the Risk of Progression in Patients with Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin (2021) in European Urology Oncology

Their frequent co-authors include Ashish M. Kamat, Neema Navai, Kelly K. Bree, David J. McConkey, and Patrick J. Hensley, indicating a collaborative approach within the oncology and urology research communities.

Colin P. Dinney's works are often published in notable journals such as The Journal of Urology, Urologic Oncology Seminars and Original Investigations, Journal of Clinical Oncology, European Urology, and British Journal of Urology. The scientist has a substantial number of publications in these high-impact venues, demonstrating consistent research activity in their fields of study.

Best Publications

  • Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy

    Woonyoung Choi;Sima Porten;Seungchan Kim;Daniel Willis

  • Erratum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer (Nature Genetics (2009) 41 (991-995))

    Xifeng Wu;Yuanqing Ye;Lambertus A. Kiemeney;Patrick Sulem

  • A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.

    Aurélie Kamoun;Aurélien de Reyniès;Yves Allory;Yves Allory;Gottfrid Sjödahl

  • Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice.

    Paul Perrotte;Takashi Matsumoto;Keiji Inoue;Hiroki Kuniyasu

  • miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy

    Liana Adam;Meng Zhong;Woonyoung Choi;Wei Qi

  • A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci

    Nathaniel Rothman;Montserrat Garcia-Closas;Nilanjan Chatterjee;Nuria Malats

  • Interleukin 8 Expression Regulates Tumorigenicity and Metastases in Androgen-independent Prostate Cancer

    Keiji Inoue;Joel W. Slaton;Beryl Y. Eve;Sun Jin Kim

  • Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma

    David A. Levy;Joel W. Slaton;David A. Swanson;Colin P.N. Dinney

  • Interferon-α-mediated Down-Regulation of Angiogenesis-related Genes and Therapy of Bladder Cancer Are Dependent on Optimization of Biological Dose and Schedule

    Joel W. Slaton;Paul Perrotte;Keiji Inoue;Colin P. N. Dinney

  • Use of the University of California Los Angeles Integrated Staging System to Predict Survival in Renal Cell Carcinoma: An International Multicenter Study

    Jean Jacques Patard;Hyung L. Kim;John S. Lam;Frederick J. Dorey

  • Metastatic Model for Human Prostate Cancer Using Orthotopic Implantation in Nude Mice

    Robert A. Stephenson;Colin P. N. Dinney;Kazuo Gohji;Nelson G. Ordonez

  • Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer.

    David J. McConkey;Woonyoung Choi;Lauren Marquis;Frances Martin

  • Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus

    Jonathan C Nesbitt;Ernesto R Soltero;Colin P.N Dinney;Garrett L Walsh

  • Integrated therapy for locally advanced bladder cancer : final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC

    Randall Millikan;Colin Dinney;David Swanson;Paul Sweeney

  • Inhibition of Basic Fibroblast Growth Factor Expression, Angiogenesis, and Growth of Human Bladder Carcinoma in Mice by Systemic Interferon-α Administration

    Colin P. N. Dinney;Diane R. Bielenberg;Paul Perrotte;Reuven Reich

  • Paclitaxel Enhances the Effects of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody ImClone C225 in Mice with Metastatic Human Bladder Transitional Cell Carcinoma

    Keiji Inoue;Joel W. Slaton;Paul Perrotte;Darren W. Davis

  • Evaluation of Genetic Variants in MicroRNA-Related Genes and Risk of Bladder Cancer

    Hushan Yang;Colin P. Dinney;Yuanqing Ye;Yong Zhu

  • Focus on bladder cancer

    Colin P.N. Dinney;David J. McConkey;Randall E. Millikan;Xifeng Wu

  • Clinical model of lifetime cost of treating bladder cancer and associated complications.

    Elenir B.C. Avritscher;Catherine D. Cooksley;H. Barton Grossman;Anita L. Sabichi

  • Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use

    Vipulkumar Dadhania;Miao Zhang;Li Zhang;Jolanta Bondaruk

Frequent Co-Authors

Ashish M. Kamat
Ashish M. Kamat The University of Texas MD Anderson Cancer Center
H. Barton Grossman
H. Barton Grossman The University of Texas MD Anderson Cancer Center
Bogdan Czerniak
Bogdan Czerniak The University of Texas MD Anderson Cancer Center
David J. McConkey
David J. McConkey Johns Hopkins University
Wassim Kassouf
Wassim Kassouf McGill University
Xifeng Wu
Xifeng Wu Zhejiang University
Louis L. Pisters
Louis L. Pisters The University of Texas MD Anderson Cancer Center
Seth P. Lerner
Seth P. Lerner Baylor College of Medicine
Surena F. Matin
Surena F. Matin The University of Texas MD Anderson Cancer Center
Jian Gu
Jian Gu The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

There are a range of flexible online degrees for students interested in Medicine, Healthcare Administration, or advanced nursing roles. For those considering a leadership path outside direct patient care, cahme-accredited online mha programs offer training in healthcare management and policy, preparing graduates for high-demand administrative roles.

Registered Nurses hoping to advance without the time commitment of clinical hours should explore the best online rn to bsn programs without clinical requirements. These programs are ideal for working RNs seeking career growth and higher pay while balancing existing responsibilities.

If you are looking to earn a doctoral-level qualification in nursing, dnp online programs can help you reach the highest levels of nursing practice in less time, with some programs offering accelerated paths to completion. For those concerned about tuition costs, there are also affordable dnp programs designed to make doctoral studies more accessible.

Exploring these pathways can open new opportunities in both clinical and non-clinical healthcare roles, whether you’re aiming for leadership, direct patient care, or academic positions.

Best Scientists Citing Colin P. Dinney

Trending Scientists